American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on May 7, 2025

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update

Worldwide revenue of $372.8 million in the first quarter 2025 GAAP fully diluted earnings per share of $1.02, compared to $1.87 in the first quarter of 2024; adjusted fully diluted earnings per share of $1.53, compared to $1.69 in the first quarter of 2024 …

EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments

EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments

– Enrollment continues to exceed expectations in DURAVYU™ Phase 3 wet AMD clinical trials with over 90% of patients randomized into the LUGANO trial and over 50% into the LUCIA trial, reinforcing confidence in enrollment completion in 2H 2025 and expected …

Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales SYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product revenue of $130.2 million Increase in demand offset by …

Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

New York, NY, May 07, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new results with LX-101 in Thyroid Eye Disease …

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis double-stranded RNA ligases Management will host a conference …

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

-- First quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $37.7 million -- -- Setmelanotide pivotal Phase 3 TRANSCEND trial met primary endpoint with -19.8% placebo-adjusted BMI reduction in patients (N=120) with acquired …

Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025

Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on …

Robex Lodges Replacement Prospectus for IPO

Robex Lodges Replacement Prospectus for IPO

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, May 07, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (TSX-V: RBX) announces that, in reference to …

Newcore Gold Drilling Intersects 2.25 g/t Gold over 56.0 Metres from 96 Metres and 1.16 g/t Gold over 72.0 Metres from 104 Metres at the Enchi Gold Project, Ghana

Newcore Gold Drilling Intersects 2.25 g/t Gold over 56.0 Metres from 96 Metres and 1.16 g/t Gold over 72.0 Metres from 104 Metres at the Enchi Gold Project, Ghana

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …

Compliance First: OFUYC Releases In-Depth Stablecoin Audit Solution

Compliance First: OFUYC Releases In-Depth Stablecoin Audit Solution

GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- The digital currency market is undergoing regulatory consolidation, with stablecoin compliance becoming a key focus. To address global requirements for reserve auditing, transparency, and anti- …

OFUYC si concentra sull'audit di conformità delle stablecoin, promuovendo un nuovo modello di regolamentazione degli asset digitali

OFUYC si concentra sull'audit di conformità delle stablecoin, promuovendo un nuovo modello di regolamentazione degli asset digitali

GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- Il mercato delle valute digitali sta entrando in una nuova fase di consolidamento normativo, con la conformità delle stablecoin che diventa un punto focale per il settore. Per rispondere alle …

First Atlantic Nickel Starts Phase 2 Drilling to Expand New Nickel Discovery at RPM Zone in District-Scale Atlantic Nickel Project

First Atlantic Nickel Starts Phase 2 Drilling to Expand New Nickel Discovery at RPM Zone in District-Scale Atlantic Nickel Project

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is excited to announce the commencement of Phase 2 drilling at the RPM Zone on its 100%- …

Oculis to Present at Upcoming May Investor Conferences

Oculis to Present at Upcoming May Investor Conferences

ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, …

UNICOM Engineering Announces Strategic Partnership with E4 Computer Engineering to Deliver Advanced AI Infrastructure Solutions

UNICOM Engineering Announces Strategic Partnership with E4 Computer Engineering to Deliver Advanced AI Infrastructure Solutions

CANTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- UNICOM Engineering announces a strategic partnership with E4 Computer Engineering, the Italian leader in High-Performance Computing (HPC) and AI-driven solutions. This collaboration expands UNICOM Engineering …

BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that interrupts the NLRP3 inflammasome and boosts macrophage clearance of pathogens. Results from this landmark study expected to inform therapeutic strategies beyond ARDS, …

ZenaTech expande su oficina en Irlanda ofreciendo Dron como Servicio (DaaS), incluyendo agricultura de precisión, a un mercado europeo con un crecimiento anual del 28,6%

ZenaTech expande su oficina en Irlanda ofreciendo Dron como Servicio (DaaS), incluyendo agricultura de precisión, a un mercado europeo con un crecimiento anual del 28,6%

VANCOUVER, Columbia Británica, May 06, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), una empresa de tecnología especializada en drones con IA (inteligencia artificial), Dron como un Servicio (DaaS), soluciones …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service